Papers
1
Total Citations
109
H-Index
1
About
Dr. Linda Jones is a leading figure in liquid biopsy research, with her work fundamentally shaping how circulating cell-free DNA (cfDNA) is collected and analyzed for cancer management. Her primary contributions lie in understanding the critical pre-analytical variables that determine the accuracy of cfDNA tests. In her seminal 2018 paper, "Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients," which has garnered over 109 citations, Dr. Jones demonstrated how standard blood collection and processing protocols inadvertently elevate cfDNA levels through leukocyte lysis, thereby diluting the crucial signal from circulating tumor DNA (ctDNA). This work established essential best practices for the field, ensuring that ctDNA—often present as a minor fraction of total cfDNA—can be reliably detected. Her research has directly improved the sensitivity and specificity of noninvasive cancer diagnostics, enabling more precise monitoring of tumor dynamics and treatment response. Dr. Jones’s rigorous focus on methodological standardization has made her a trusted authority in the liquid biopsy community, and her findings continue to guide both clinical trial design and routine laboratory workflows.
Research Focus
Key Achievements
Top Papers
- 1